TEM (Tempus AI) Expected net earnings per share growth this year

TEM (Tempus AI, Inc) - company brandmark

Tempus AI, Inc (TEM) monetizes vast arrays of medical data for pharmaceutical behemoths by expanding its network of sequencing laboratories. The authority of Tempus AI, Inc (TEM) in precision medicine and the trust physicians place in the quality of its genomic analysis confirm the company's leadership. The year-over-year percentage change in EPS on GURU.Markets reflects profit dynamics, where the current level is 92.10, helping to assess the effectiveness of the strategy to capture the personalized therapy market.

TEM (Tempus AI Inc) Earnings growth in current year history from 06/15/2024 to 11/11/2026

Financial and market metric breakdowns for tempus.com (TEM)

- market value and analyst target forecast:
Stock Price Tempus Labs|TEM - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Tempus Labs|TEM - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Accounting Value of a Share Tempus|TEM - Book Capitalization|Market Capitalization to Book Value tempus.com|TEM - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio Tempus AI, Inc|TEM - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Tempus|TEM - Company Total Debt|Debt to Book Capital Tempus Labs|TEM - Company Long-Term Debts|Short-Term Debt Tempus|Quick Liquidity Indicator tempus.com
- net income and valuation multiples indicators:
TEM - Net Profit|Net Profit Forecast Tempus AI, Inc|TEM - Price to Earnings Ratio|Price to Future Earnings Ratio Tempus AI Inc|TEM - PEG Multiple|EV/EBITDA Multiple Tempus Labs|TEM - Operating profit before deduction of amortization|Earnings per share for the last four quarters Tempus|TEM - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months tempus.com|TEM - Earnings per share growth in current year|Expected earnings per share growth for next year Tempus AI, Inc
Summary company analysis:Tempus AI, Inc. - TEM
Brand item of Tempus AI

This indicator measures the year-over-year dynamics of earnings per share, allowing investors to quickly assess business scaling rates and filter out market volatility. By analyzing the percentage deviation of EPS from the previous year's level, one can determine how effectively Tempus AI, Inc (TEM) converts aggressive spending on recruiting elite AI developers and genomic analysts into tangible financial results.

Direct competitors

Qiagen NV (QGEN) - Earnings growth in current year|IONS (Ionis Pharma) - Earnings growth in current year|Repligen Inc. (RGEN) - Expected net earnings per share growth this year|Net earnings per share growth this year RNA (Avidity Biosciences)|CRSP (crisprtx.com) - Earnings per share increase in current year|Earnings growth in current year WGS (GeneDx)|Expected net earnings per share growth this year Ultragenyx Pharmaceutical Inc. (RARE)|BEAM - Earnings per share growth in current year|SRPT (Sarepta Corp) - Earnings per share growth this year|TWST: Earnings growth in current year|Net earnings per share growth this year 10xgenomics.com|Net earnings per share growth this year NTLA|STOK (Stoke Therapeutics Inc) - Net earnings per one share growth for the current year|Earnings growth in current year BLFS|WVE - Earnings per share growth rate in current year|Earnings per share growth in current year Maze Therapeutics Inc MAZE|SION - Net earnings per share growth this year|Prime Medicine - Earnings growth in current year|TSHA (Taysha Gene Therapies Inc) - Earnings per share growth this year|uniQure Corp (QURE) - Earnings per share growth in current year|Earnings per share growth this year MGTX|RGNX (REGENXBIO Inc.) - Earnings growth in current year|Earnings growth in current year solidbio.com|Net earnings per share growth this year OCGN (Ocugen)|Net earnings per one share growth for the current year PACB|Earnings growth in current year BNTC (Benitec)|Design Corp (DSGN) - Earnings per share growth rate in current year|RCKT - Earnings per share growth in current year|4dmoleculartherapeutics.com (FDMT) - Net earnings per share growth this year|lexeotx.com (LXEO) - Earnings per share growth in current year|Earnings per share trend in current year KRRO (Korro Bio)|Net earnings per share growth this year EDIT|Earnings growth in current year Silence Therapeutics Corp|Earnings per share growth in current year ProQR Therapeutics N.V. (PRQR)|Expected net earnings per share growth this year codexis.com|Sangamo Therapeutics, Inc. - Net earnings per share growth this year|Earnings per share increase in current year NAUT|Metagenomi, Inc - Earnings growth in current year|DTIL - Earnings growth in current year|GBIO: Earnings growth in current year|BOLD - Expected net earnings per share growth this year|Net earnings per share growth this year XCUR|IMNN: Earnings per share increase in current year|Earnings growth in current year PHIO|Expected net earnings per share growth this year mustangbio.com|Earnings per share growth in current year TransCode Therapeutics, Inc. RNAZ|BNGO: Earnings per share growth this year|Applied DNA Sciences, Inc. - Earnings growth in current year|bluebird bio Inc. (BLUE) - Net earnings per share growth this year|IPA (immunoprecise.com) - Net earnings per share growth this year|OMGA: Net earnings per one share growth for the current year|OMIC (Singular Genomics Systems) - Earnings growth in current year|Earnings per share growth rate in current year regulusrx.com RGLS|Earnings per share growth in current year Syros Pharmaceuticals, Inc. (SYRS)|Net earnings per share growth this year Telesis Bio Inc. TBIO|Earnings growth in current year TCON (TRACON)|UBX: Earnings per share growth this year